Fosfomycin tromethamine. Antibiotic of choice in the female patient: A multicenter study

Central European Journal of Urology

Volumn 68, Issue 3, 2015, Pages 371-375

  Khawaja, Abdul Rouf ^a,b   Khan, Farzana Bashir ^a,b   Dar, Tanveer Iqbal ^a,b   Bhat, Arif Hameed ^a,b   Wani, Mohd Saleem ^a,b   Wazir, Baldev Singh ^a,b  

^a SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

^b GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

Asymptomatic bacteriuria (ASB); Fosfomycin trometamol; Lower urinary tract symptoms; Urinary tract infections

Indexed keywords

EXTENDED SPECTRUM BETA LACTAMASE; FOSFOMYCIN TROMETAMOL;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; ASYMPTOMATIC BACTERIURIA; BACKACHE; BACTERIAL CLEARANCE; BACTERIUM ISOLATE; CLINICAL EFFECTIVENESS; COLIFORM BACTERIUM; DIARRHEA; DISEASE SEVERITY; DIZZINESS; ENDOUROLOGY; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FEMALE; FOLLOW UP; GRAM NEGATIVE BACTERIUM; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHUMAN; PROSPECTIVE STUDY; PROTEUS; PSEUDOMONAS AERUGINOSA; QUESTIONNAIRE; RHINITIS; SINGLE DRUG DOSE; STAPHYLOCOCCUS AUREUS; SYMPTOMATOLOGY; URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE; VAGINAL PRURITUS; VOMITING;

EID: 84944621170     PISSN: 20804806     EISSN: 20804873     Source Type: Journal    
DOI: 10.5173/ceju.2015.590     Document Type: Article

References (17)

1. Patterson TF, Andriole VT. Bacteriuria in pregnanacy. Infect Dis Clin North Am. 1987; 1: 807-822.
2. Mikhail MS, Anyaegbunam A. Lower Urinary Tract dysfunction in pregnancy: a review. Obstet Gynecol Surv. 1995; 50: 675-683.
3. Kass EH, Finland M. Asymptomatic infections of the urinary tract. J Urol. 2002; 168: 420-424.
4. Stein G, Funfstuck R. Asymptomatic bacteriuria-what to do. Nephrol Dial Transplant. 1999; 14: 1618-1621.
5. Hendlin D, Stapley EO, Jackson M, et al. Phosphonomycin. A new antibiotic produced by strains of streptomyces. Science. 1969; 166: 122-123.
6. Falagas ME, Giannopoulou KP, Kokolakis GN, Rafailidis PI. Fosfomycin: use beyond urinary tract and gastrointestinal infections. Clin Infect Dis. 2008; 46: 1069-1077.
7. Woodruff HB, Mata JM, Hernandez S, et al. Fosfomycin: laboratory studies. Chemotherapy. 1977; 23: 1-22.
8. Takahashi K, Kanno H. Synergistic activities of combination of beta lactams, fosfomycin, and tobramycin against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1984; 26: 789-791.
9. Chin NX, Neu NM, Neu HC. Synergy of fosfomycin with beta-lactam antibiotics against staphylococci and aerobic gram-negative bacilli. Drugs Exp Clin Res. 1986; 12: 943-947.
10. Okazaki M, Suzuki K, Asano N, et al. Effectiveness of fosfomycin combined with other antimicrobial agents against multidrug-resistant Pseudomonas aeruginosa isolates using the efficacy time index assay. J Infect Chemother. 2002; 8: 37-42.
11. Patel SS, Balfour JA, Bryson HM. Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as single-dose oral treatment for acute uncomplicated lower urinary tract infections. Drugs. 1997; 53: 637-656.
12. Kutlay S, Kutlay B, Karaahmetoglu O, Ak C, Erkaya S. Prevalance, detection and treatment of asymptomatic bacteriuria in a Turkish obstetric population. J Reprod Med. 2003; 48: 627-630.
13. Teppa RJ, Roberts JM. The uriscreen test to detect significant asymptomatic bacteriuria during pregnancy. J Soc Gynecol Investig. 2005; 12: 50-53.
14. Enayat K, Fariba F, Bahram N. Asymptomatic bacteriuria among pregnant woman referred to outpatient clinics in Sanandaj, Iran. Int Braz J Urol. 2008; 34: 699-704.
15. Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE. Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis. 2010; 10: 43-50.
16. Maraki S, Samonis G, Rafailidis PI, Vouloumanou EK, Mavromanolakis E, Falagas ME. Susceptibility of urinary tract bacteria to fosfomycin. Antimicrob Agents Chemother. 2009; 53: 4508-4510.
17. Lu CL, Liu CY, Huang YT, et al. Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods. Antimicrob Agents Chemother. 2011; 55: 4295-4301.